| Literature DB >> 35911846 |
Matthew M Nour1, Katherine Beck2, Yunzhe Liu1, Atheeshaan Arumuham2, Mattia Veronese2, Oliver D Howes2, Raymond J Dolan1.
Abstract
Background and Hypotheses: Hippocampal replay and associated high-frequency ripple oscillations are among the best-characterized phenomena in resting brain activity. Replay/ripples support memory consolidation and relational inference, and are regulated by N-methyl-D-aspartate receptors (NMDARs). Schizophrenia has been associated with both replay/ripple abnormalities and NMDAR hypofunction in both clinical samples and genetic mouse models, although the relationship between these 2 facets of hippocampal function has not been tested in humans. Study Design: Here, we avail of a unique multimodal human neuroimaging data set to investigate the relationship between the availability of (intrachannel) NMDAR binding sites in hippocampus, and replay-associated ripple power, in 16 participants (7 nonclinical participants and 9 people with a diagnosis of schizophrenia, PScz). Each participant had both a [18F]GE-179 positron emission tomography (PET) scan (to measure NMDAR availability, V T ) and a magnetoencephalography (MEG) scan (to measure offline neural replay and associated high-frequency ripple oscillations, using Temporally Delayed Linear Modeling). StudyEntities:
Keywords: Psychosis; excitation-inhibition balance; inference; replay; sharp wave ripple
Year: 2022 PMID: 35911846 PMCID: PMC9334566 DOI: 10.1093/schizbullopen/sgac044
Source DB: PubMed Journal: Schizophr Bull Open ISSN: 2632-7899
Participant Demographic, Cognitive, Clinical and PET variables. (Information From Full PET-MEG Subsample)
| Variable | Control | PScz | Group Comparison |
|---|---|---|---|
| Demographics | |||
| Sample size | 7 | 10 | |
| Gender | 1F, 6M | 3F, 7M | χ 2 = 0.57 ( |
| Age (mean, SD) | 28.7 (5.46) | 26.4 (4.43) |
|
| Years in education (mean, SD) | 20.0 (0.93) | 15.90 (3.98) |
|
| Employment status [F/P/U] | 1/ 2/ 4 | 2/ 2/ 6 | χ 2 = 3.24 ( |
| Handedness | 5R, 2L | 10R, 0L | χ 2 = 9.26 ( |
| Ethnicity [W/BAME/Other]† | 2/ 5/ 0 | 2/ 7/ 1 | χ 2 = 9.26 ( |
| Alcohol units week−1 (mean, SD) | 9.29 (6.26) | 0.10 (0.32) |
|
| Current cannabis (not within 1 week) | 4 | 4 | χ 2 = 0.49 ( |
| Current smoker (not within 6 hrs) | 4 | 3 | χ 2 = 0.01 ( |
| Cognitive | |||
| IQ (SD) | 105.4 (2.94) | 99.7 (8.86) |
|
| Digit span forward (mean, SD) | 6.71 (0.95) | 5.75 (1.38) |
|
| Digit span backward (mean, SD) | 4.07 (0.93) | 3.30 (0.82) |
|
| Psychiatric | |||
| Depressive symptoms‡ (mean, SD) | 0.29 (0.49) | 10.10 (6.59) |
|
| Positive symptoms§ (mean, SD) | 7.14 (0.38) | 17.20 (7.35) |
|
| Negative symptoms§ (mean, SD) | 7.00 (0.00) | 19.0 (6.85) |
|
| General psychopathology§ (mean, SD) | 16.14 (0.38) | 29.0 (8.69) |
|
| General functioning** (mean, SD) | 97.14 (4.88) | 63.2 (13.09) |
|
| Clinical details | |||
| No. taking medication | — | 5 | — |
| Months since 1st symptom (median, IQR) | — | 43 (36) | — |
| No. acute episodes (median, IQR) | — | 3 (4) | — |
| No. admissions (median, IQR) | — | 1.5 (3) | — |
| PET | |||
| Injected Dose MBq (mean, SD) | 139.93 (9.31) | 140.68 (4.79) |
|
| Total motion mm (mean, SD) | 8.70 (6.48) | 15.10 (11.16) |
|
| Hippocampal volume mm3, bilateral (mean, SD) | 8732 (635) | 9066 (629) |
|
| Brain K1 (mean, SD) | 0.28 (0.08) | 0.24 (0.05) |
|
| Hippocampus K1 (mean, SD) | 0.26 (0.06) | 0.23 (0.06) |
|
| Time between PET and MEG, years (mean, SD) | 1.61 (0.79) | 1.20 (0.91) |
|
*F = full-time employed, P = part-time employed, U = unemployed (inc. student).
†W = White. BAME = Black, Asian, and Minority Ethnic. Other (inc. multiple groups).
‡Montgomery Asberg Depression Rating Scale (MADRS), floor = 0.
§Positive and Negative Syndrome Scale (PANSS) scale, floor = 7 (pos), 7 (neg), 16 (gen).
**General Assessment of Functioning (GAF) scored from 0 to 100.
¶D2/3 receptor antagonist medication per medicated PScz: (1) aripiprazole 10 mg day−1, (2) lurasidone 37 mg day−1, (3) aripiprazole 400 mg month−1 (depot), (4) olanzapine 7.5 mg day−1, (5) paliperidone 50 mg month−1 (depot).
++Group comparisons: For continuous variables, unpaired t test (t) or Wilcoxon rank sum test (z) (for non-normally distributed data). For categorical variables, Chi squared test (χ 2). Two-tailed hypotheses. SD: standard deviation. IQR: interquartile range. Time-sensitive variables (eg, age, symptom/cognitive scores) recorded at MEG. PScz: people with a diagnosis of schizophrenia. K1 reflects the rate constant for transfer from arterial plasma to tissue (mL cm−3 min−1).
Fig. 1.Quantifying replay MEG and NMDAR availability PET. (A) (Left) Applied Learning MEG task.[7] During MEG participants needed to infer the sequential relationships (“structural sequences”) between 8 task pictures, from scrambled “visual sequences” containing these pictures. To do this they needed to leverage the knowledge of how visual sequences mapped to structural sequences (“unscrambling rule”), which was learned prior to MEG (see “MEG Applied Learning Task”). The Applied Learning task was followed by a 5-minute awake rest session. (Right) In MEG data from this postlearning rest session, we tested for the presence of spontaneous neural replay of correctly inferred task transitions using a decoding-based analytic approach. In Nour et al.,[7] we identified transient increases in high frequency “ripple” power (120–150 Hz) coincident with replay onsets. Spectrogram shows the average high-frequency power increase at putative replay onset, averaged over all putative replay events, MEG sensors, and participants (n = 53 [27 controls, 26 PScz], the MEG sample reported in Nour et al.[7]) (plotted as t-statistic of 1-sample t test, 2-tailed). 0 ms represents time of thresholded replay event (time samples exceeding the subject-specific 95th percentile for replay evidence, preceded by a low-reactivation baseline, see “Materials and Methods” and in Nour et al.[7]). We further source localized repay-associated ripple power increases to hippocampus. Significant source localization cluster of replay-associated ripple power reproduced from Nour et al.[7] (n = 53 [27 controls, 26 PScz], significance at whole-brain PFWE < .05, cluster-based permutation test, 5000 permutations, cluster-defining threshold t > 3. (B) (Left) N-methyl-D-aspartate receptor (NMDAR) availability was estimated for each participant using [18F]GE-179 PET. Mean [18F]GE-179 volume of distribution (V) at each voxel, indexing availability of open NMDARs (ie, intrachannel binding sites) (mean over n = 16 participants, 9 PScz, and 7 controls). (Right) t values of the group difference (control > PScz) in mean V estimate at each voxel. Control participants exhibit numerically greater mean V estimates throughout the cortex compared to PScz, but this group difference is not statistically significant. Note very liberal image thresholding at t > 0.50, and excluding cerebellum, for illustration purposes only. For all images: neurological orientation, and MNI coordinates of section as given.
Fig. 2.Relationship between N-methyl-D-aspartate receptor (NMDAR) availability and ripple power: voxelwise analysis. (A)(Red) Voxel clusters exhibiting a significant linear relationship between [18F]GE-179 V and replay-associated ripple power, family-wise error corrected at whole-brain cluster level (cluster-level PFWE < .05 (cluster-defining threshold [CDT] P < .001 (uncorrected), critical cluster size = 747). Effect is derived from the combined sample of PScz and controls, using a multiple regression analysis (at each voxel) regressing [18F]GE-179 V onto replay-associated ripple power, controlling for group differences in mean [18F]GE-179 V and group * ripple interaction. Replay-associated ripple power is defined as subject-specific ripple power detected at replay onsets during a post-learning rest session in MEG (mean 120–150 Hz power increase at replay onset, measured overall magnetoencephalography (MEG) sensors, compared to a pre-onset baseline, as in Nour et al.[7] (Green) Putative intracranial source of replay-associated ripple power, identified from previously published beamforming analysis (whole-brain cluster-level significance PFWE < .05, 5000 permutations, CDT t > 3.[7] Beamforming result reproduced in figure 1A). (B) Small volume correction (SVC) analysis of the voxelwise linear association between [18F]GE-179 V and replay-associated ripple power (shown in (A)), thresholded at PSVC FWE < .05 (voxel level). (Left) Small-volume ROI is bilateral hippocampal (HPC) anatomical mask, showing bilateral significant peak effects: Left peak MNI = [−16, −14, −22], peak-level PFWE = .012. Right peak MNI = [28, 10, −28], peak-level PFWE = .028. (Right) Small-volume ROI is the left hippocampal (HPC) cluster identified in the previously published beamforming analysis of replay-associated ripple power (green cluster in (A), “functional” mask). Peak-level effect: Left peak MNI = [−16, −14, −26], peak-level PFWE = 0.008. For all images: Neurological orientation, MNI coordinates of view [x = −23, y = −9]. Sample: n = 9 PScz, n = 7 controls.
Fig. 3.Relationship between N-methyl-D-aspartate receptor (NMDAR) availability ([18F]GE-179 V) and ripple power: Hippocampal region of interest (ROI) analysis. Hippocampal [18F]GE-179 V estimate derived from bilateral anatomical hippocampal ROI (as in figure 2B, left). (A) Control participants. (B) People with a diagnosis of schizophrenia (PScz). Statistics are from Pearson’s correlation coefficient. Sample: n = 9 PScz, n = 7 controls.